IPCA Laboratories Limited (NSE: IPCALAB) stock price moves up 10% intraday to ₹1910.0, extending gains and nearing resistance at ₹1970.
IPCA Laboratories Limited (IPCALAB) stock moves up 7% intraday to ₹1865.1, extending gains in the Healthcare sector.
Natco Pharma Limited (NATCOPHARM) experiences a 6% intraday decline to ₹892.6, signaling a breakdown in trendline status.
Alkem Laboratories Limited (ALKEM) announces 11% revenue growth for Q1FY27, with strong performance in India and international markets.
Marksans Pharma Limited (MARKSANS) stock clears its 6M resistance trendline, gaining 5% intraday. This breakout move is backed by Q1fy27 profitability at all.
Gaudium IVF and Women Health Limited (NSE: GAUDIUMIVF) reports steady Q1FY27 revenue of ₹19.4 Cr, up 9.13% YoY.
Zota Health Care Limited (ZOTA) reports a 67.59% YoY revenue growth in Q1FY27, reaching ₹17,360.23 lakhs, driven by network expansion.
Max Healthcare Institute Ltd (MAXHEALTH) reports a 16% YoY revenue rise to ₹2,982 Cr in Q1 FY27, with network expansion and strategic acquisitions.
IPCA Laboratories Limited (NSE: IPCALAB) stock moves up 6% intraday, nearing resistance at ₹1877.0 in the Healthcare sector.
Thyrocare Technologies Limited (NSE: THYROCARE) stock shows pressure after breakout, down 7% intraday at ₹596.65.